Background RECORD is a non-interventional, single arm cohort study assessing the real-world effectiveness of Budesonide/Glycopyrronium/Formoterol therapy in COPD patients from Germany (GER) and United Kingdom (UK) over 12 months. Its patient-centric approach includes several patient-reported outcomes (PROs) along with clinical parameters.
No takes yet. Share an insight, caveat, or question.
Watz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: